These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 29016617)
1. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617 [TBL] [Abstract][Full Text] [Related]
2. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145 [TBL] [Abstract][Full Text] [Related]
3. A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia. Li H; Xing C; Zhou B; Ye H; Feng J; Wu J; Gao S Exp Hematol; 2018 May; 61():59-68.e5. PubMed ID: 29452230 [TBL] [Abstract][Full Text] [Related]
4. [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model]. Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):253-8. PubMed ID: 17706117 [TBL] [Abstract][Full Text] [Related]
5. Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis. Mesci A; Huang X; Taeb S; Jahangiri S; Kim Y; Fokas E; Bruce J; Leong HS; Liu SK Br J Cancer; 2017 May; 116(10):1350-1357. PubMed ID: 28419078 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Li S; Meng H; Zhou F; Zhai L; Zhang L; Gu F; Fan Y; Lang R; Fu L; Gu L; Qi L Pathol Res Pract; 2013 Mar; 209(3):179-83. PubMed ID: 23399321 [TBL] [Abstract][Full Text] [Related]
8. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102 [TBL] [Abstract][Full Text] [Related]
9. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer. Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380 [TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a. Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225 [TBL] [Abstract][Full Text] [Related]
11. Improvement of membranous nephropathy by inhibition of miR-193a to affect podocytosis via targeting WT1. Li J; Chen Y; Shen L; Deng Y J Cell Biochem; 2019 Mar; 120(3):3438-3446. PubMed ID: 30242881 [TBL] [Abstract][Full Text] [Related]
12. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687 [TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles carrying miR-193a derived from mesenchymal stem cells impede cell proliferation, migration and invasion of colon cancer by downregulating FAK. Ying H; Lin F; Ding R; Wang W; Hong W Exp Cell Res; 2020 Sep; 394(2):112144. PubMed ID: 32540398 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells. Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864 [TBL] [Abstract][Full Text] [Related]
18. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985 [TBL] [Abstract][Full Text] [Related]
19. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer. Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis. Wu H; Zhou C Biochem Biophys Res Commun; 2018 Feb; 496(2):738-745. PubMed ID: 29355524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]